Cloning and Expression of Murine CYP2Cs and Their Ability to Metabolize Arachidonic Acid

This publication has 49 references indexed in Scilit:

• Identification of Residues 99, 220, and 221 of Human Cytochrome P450 2C19 as Key Determinants of Omeprazole Hydroxylase Activity
  Published by Elsevier ,1996
• The role of S‐mephenytoin hydroxylase (CYP2C19) in the metabolism of the antimalarial biguanides.
  British Journal of Clinical Pharmacology, 1995
• Biochemistry and molecular biology of the human CYP2C subfamily
  Pharmacogenetics, 1994
• The role of S‐mephenytoin 4'‐hydroxylase in imipramine metabolism by human liver microsomes: a two‐enzyme kinetic analysis of N‐ demethylation and 2‐hydroxylation.
  British Journal of Clinical Pharmacology, 1994
• Evidence That CYP2C19 is the Major (S)-Mephenytoin 4'-Hydroxylase in Humans
  Biochemistry, 1994
• Incidence of S-mephenytoin hydroxylation deficiency in a Korean population and the interphenotypic differences in diazepam pharmacokinetics
  Clinical Pharmacology & Therapeutics, 1992
• Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions
  Chemical Research in Toxicology, 1992
• Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450IIC subfamily
  Biochemistry, 1991
• Tolbutamide and phenytoin hydroxylations by cDNA-expressed human liver cytochrome P4502C9
  Biochemical and Biophysical Research Communications, 1991
• Propranolol's metabolism is determined by both mephenytoin and debrisoquin hydroxylase activities
  Clinical Pharmacology & Therapeutics, 1989